Haemonetics Corp (HAE)

Cost of Revenue

$576.17M

TTM · Period ending: · USD

HAE logo

HAE Cost of Revenue

Latest reported$576.17M
HAE TTM Cost of Revenue ($57.80M → $576.17M)
High-resolution chart · PNG

HAE cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Haemonetics Corp Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
136,199,000
126,950,000
125,160,000
126,491,000
123,049,000
121,700,000
125,500,000
122,900,000
123,600,000
123,900,000
91,500,000
108,500,000
116,400,000
127,100,000
164,900,000
152,700,000
147,100,000
137,900,000
126,200,000
118,300,000
113,900,000
110,500,000
109,200,000
108,600,000
107,200,000
103,800,000
99,900,000
97,500,000
95,400,000
94,200,000
92,500,000
92,300,000
91,300,000
88,700,000
86,000,000
82,000,000
79,900,000
78,500,000
57,800,000
38,500,000
18,700,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.